SEC Form 4 · accession 0001209191-17-055649
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John R Beaver
Officer — SVP & Chief Financial Officer
Period of report
Oct 2, 2017
Accepted (ET)
Oct 4, 2017 · 12:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.59 | Oct 2, 2017 | A | 600,000 | A | — | Oct 2, 2027 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1The stock option vests as follows: 100,000 option shares vest on the one-year anniversary of grant, 300,000 option shares vest in equal monthly amounts over a 36-month period, commencing on the 13th month anniversary of the date of grant, and 200,000 option shares vest in accordance with performance-based criteria established by the Compensation Committee of the Board of Directors. The vesting of the stock option is subject to the Reporting Person's continued service with the Company through the applicable vesting dates.